Chemical Component Summary

Name(3alpha,8alpha)-17-(1H-benzimidazol-1-yl)androsta-5,16-dien-3-ol
Identifiers(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
FormulaC26 H32 N2 O
Molecular Weight388.545
TypeNON-POLYMER
Isomeric SMILESC[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4n5cnc6c5cccc6)C)O
InChIInChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1
InChIKeyPAFKTGFSEFKSQG-PAASFTFBSA-N

Chemical Details

Formal Charge0
Atom Count61
Chiral Atom Count6
Bond Count66
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB12415 
NameGaleterone
Groups investigational
DescriptionGaleterone has been used in trials studying the treatment of Prostate Cancer.
SynonymsGaleterone
Categories
  • Androstanes
  • Androstenes
  • Enzyme Inhibitors
  • Fused-Ring Compounds
  • Heterocyclic Compounds, Fused-Ring
CAS number851983-85-2

Related Resource References

Resource NameReference
Pharos CHEMBL2105738
PubChem 11188409
ChEMBL CHEMBL2105738